Duloxetine Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Duloxetine Hydrochloride
Health Canada Patents

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

Contact Supplier

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Contact Supplier

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

Duloxetine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

121 API Suppliers, 43 USDMF, 32 CEP/COS, 12 JDMF, 19 EU WC, 26 KDMF, 19 NDC API, 57 Listed Suppliers, $ API Reference Price

121 API Suppliers
43 USDMF
32 CEP/COS
12 JDMF
19 EU WC
26 KDMF
19 NDC API
57 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

73 Drugs in Development

73 Drugs in Development

INTERMEDIATES

32 Intermediate Suppliers

32 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

602 FDF Dossiers, 98 FDA Orange Book, 282 Europe, 40 Canada, 18 Australia, 28 South Africa, 136 Listed Dossiers

602 FDF Dossiers
98 FDA Orange Book
282 Europe
40 Canada
18 Australia
28 South Africa
136 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 30MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 60MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 30MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 60MG BASE

RELATED EXCIPIENT COMPANIES

3 Evonik, 1 Rochem International Inc, 16 SPI Pharma, 17 DKSH, 8 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 3 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 35 BASF, 1 Clariant, 13 Corel Pharma Chem, 3 DFE Pharma, 2 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 9 Ideal Cures, 4 Ingredion Pharma Solutions, 22 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 11 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 5 Sigachi Industries, 2 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

70 Coating Systems & Additives, 70 Fillers, Diluents & Binders, 36 Solubilizers, 35 Disintegrants & Superdisintegrants, 33 Controlled & Modified Release, 33 Direct Compression, 29 Thickeners and Stabilizers, 28 Granulation, 22 Topical, 21 Taste Masking, 20 Parenteral, 19 Chewable & Orodispersible Aids, 17 Lubricants & Glidants, 16 Film Formers & Plasticizers, 11 Co-Processed Excipients, 9 Empty Capsules, 9 Emulsifying Agents, 7 API Stability Enhancers, 6 Surfactant & Foaming Agents, 6 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules

70 Coating Systems & Additives
70 Fillers, Diluents & Binders
36 Solubilizers
35 Disintegrants & Superdisintegrants
33 Controlled & Modified Release
33 Direct Compression
29 Thickeners and Stabilizers
28 Granulation
22 Topical
21 Taste Masking
20 Parenteral
19 Chewable & Orodispersible Aids
17 Lubricants & Glidants
16 Film Formers & Plasticizers
11 Co-Processed Excipients
9 Empty Capsules
9 Emulsifying Agents
7 API Stability Enhancers
6 Surfactant & Foaming Agents
6 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 59 News #PharmaBuzz

1 Data Compilation #PharmaFlow
59 News #PharmaBuzz

GLOBAL SALES INFORMATION

21 US Medicaid Prescriptions, 216 Regulatory FDF Prices, 15 Annual Reports

21 US Medicaid Prescriptions
216 Regulatory FDF Prices
15 Annual Reports

MARKET PLACE

23 APIs, 7 FDF Dossiers

23 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 4 Health Canada Patents

20 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 11 USP, 14 Others

3 EDQM
11 USP
14 Others

ANALYTICAL

2 BioAnalytical Methods, 2 Analytical Methods

2 BioAnalytical Methods
2 Analytical Methods

$ API Ref.Price (USD/KG) : 216 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Gowling Lafleur Henderson LLP

filter Patent Reset all filters

4 All

01 22153856

02 22344057

filter Product Reset all filters

4 All

01 4Duloxetine Hydrochloride

filter Dosage Reset all filters

4 All

01 4Delayed-Release Capsule

filter Exp Date Reset all filters

4 All

01 22015-07-13

02 22019-09-10

Product Main Page

01

Gowling Lafleur Henderson LLP

Duloxetine Hydrochloride

ESCRS

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-07-13

Date Granted : 2005-05-10

Duloxetine Hydrochloride

Brand Name : CYMBALTA

Patent Number : 2153856

Filing Date : 1995-07-13

Strength per Unit : 30 mg

Dosage Form : Delayed-Release Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-07-13

Date Granted : 2005-05-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Lafleur Henderson LLP

Duloxetine Hydrochloride

ESCRS

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-07-13

Date Granted : 2005-05-10

Duloxetine Hydrochloride

Brand Name : CYMBALTA

Patent Number : 2153856

Filing Date : 1995-07-13

Strength per Unit : 60 mg

Dosage Form : Delayed-Release Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-07-13

Date Granted : 2005-05-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Lafleur Henderson LLP

Duloxetine Hydrochloride

ESCRS

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-09-10

Date Granted : 2008-11-18

Duloxetine Hydrochloride

Brand Name : CYMBALTA

Patent Number : 2344057

Filing Date : 1999-09-10

Strength per Unit : 30 mg

Dosage Form : Delayed-Release Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-09-10

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling Lafleur Henderson LLP

Duloxetine Hydrochloride

ESCRS

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-09-10

Date Granted : 2008-11-18

Duloxetine Hydrochloride

Brand Name : CYMBALTA

Patent Number : 2344057

Filing Date : 1999-09-10

Strength per Unit : 60 mg

Dosage Form : Delayed-Release Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-09-10

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!